Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger.

Isanaka S, Guindo O, Langendorf C, Matar Seck A, Plikaytis BD, Sayinzoga-Makombe N, McNeal MM, Meyer N, Adehossi E, Djibo A, Jochum B, Grais RF.

N Engl J Med. 2017 Mar 23;376(12):1121-1130. doi: 10.1056/NEJMoa1609462.

2.

Assignment of Opsonic Values to Pneumococcal Reference Serum 007sp for Use in Opsonophagocytic Assays for 13 Serotypes.

Burton RL, Antonello J, Cooper D, Goldblatt D, Kim KH, Plikaytis BD, Roalfe L, Wauters D, Williams F, Xie GL, Nahm MH, Akkoyunlu M.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00457-16. doi: 10.1128/CVI.00457-16. Print 2017 Feb.

3.

Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

Pawloski LC, Plikaytis BD, Martin MD, Martin SW, Prince HE, Lapé-Nixon M, Tondella ML.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e15-e21. doi: 10.1093/jpids/piw035.

PMID:
27451419
4.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.

5.

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali.

Roy Chowdhury P, Meier C, Laraway H, Tang Y, Hodgson A, Sow SO, Enwere GC, Plikaytis BD, Kulkarni PS, Preziosi MP, Niedrig M.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S586-93. doi: 10.1093/cid/civ603.

6.

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.

Holme D, Findlow H, Sow SO, Idoko OT, Preziosi MP, Carlone G, Plikaytis BD, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S563-9. doi: 10.1093/cid/civ505.

7.

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.

Price GA, Hollander AM, Plikaytis BD, Mocca BT, Carlone G, Findlow H, Borrow R, Sow SO, Diallo A, Idoko OT, Enwere GC, Elie C, Preziosi MP, Kulkarni PS, Bash MC.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S554-62. doi: 10.1093/cid/civ504.

PMID:
26553688
8.

Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac.

Tang Y, Plikaytis BD, Preziosi MP, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S531-9. doi: 10.1093/cid/civ601.

9.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.

Diallo A, Sow SO, Idoko OT, Hirve S, Findlow H, Preziosi MP, Elie C, Kulkarni PS, Parulekar V, Diarra B, Cheick Haidara F, Diallo F, Tapia M, Akinsola AK, Adegbola RA, Bavdekar A, Juvekar S, Chaumont J, Martellet L, Marchetti E, LaForce MF, Plikaytis BD, Enwere GC, Tang Y, Borrow R, Carlone G, Viviani S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S521-30. doi: 10.1093/cid/civ518.

10.

Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.

Tapia MD, Findlow H, Idoko OT, Preziosi MP, Kulkarni PS, Enwere GC, Elie C, Parulekar V, Sow SO, Haidara FC, Diallo F, Doumbia M, Akinsola AK, Adegbola RA, Kampmann B, Chaumont J, Martellet L, Marchetti E, Viviani S, Tang Y, Plikaytis BD, LaForce FM, Carlone G, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S514-20. doi: 10.1093/cid/civ672.

11.

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians.

Tapia MD, Sow SO, Haidara FC, Diallo F, Doumbia M, Enwere GC, Paranjape G, Hervé J, Bouma E, Parulekar V, Martellet L, Chaumont J, Plikaytis BD, Tang Y, Kulkarni PS, Hartmann K, Preziosi MP.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S507-13. doi: 10.1093/cid/civ626.

12.

Under treatment of pneumonia among children under 5 years of age in a malaria-endemic area: population-based surveillance study conducted in Manhica district- rural, Mozambique.

Acácio S, Verani JR, Lanaspa M, Fairlie TA, Nhampossa T, Ruperez M, Aide P, Plikaytis BD, Sacoor C, Macete E, Alonso P, Sigaúque B.

Int J Infect Dis. 2015 Jul;36:39-45. doi: 10.1016/j.ijid.2015.05.010. Epub 2015 May 14.

13.

Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.

Chen L, Schiffer JM, Dalton S, Sabourin CL, Niemuth NA, Plikaytis BD, Quinn CP.

Clin Vaccine Immunol. 2014 Nov;21(11):1512-20. doi: 10.1128/CVI.00469-14. Epub 2014 Sep 3.

14.

Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.

Patel M, Romero-Steiner S, Broderick MP, Thomas CG, Plikaytis BD, Schmidt DS, Johnson SE, Milton AS, Carlone GM, Clark TA, Messonnier NE, Cohn AC, Faix DJ.

Vaccine. 2014 Jun 24;32(30):3805-9. doi: 10.1016/j.vaccine.2014.05.001. Epub 2014 May 14.

15.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
16.

Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.

Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, Quinn K, King L, Schmink SE, Wang X, Mayer LW, Clark TA, Gaskell JR, Messonnier NE, DiOrio M, Cohn AC.

Clin Infect Dis. 2013 Aug;57(3):344-8. doi: 10.1093/cid/cit243. Epub 2013 Apr 17.

PMID:
23595832
17.

Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis.

Wu HM, Cordeiro SM, Harcourt BH, Carvalho M, Azevedo J, Oliveira TQ, Leite MC, Salgado K, Reis MG, Plikaytis BD, Clark TA, Mayer LW, Ko AI, Martin SW, Reis JN.

BMC Infect Dis. 2013 Jan 22;13:26. doi: 10.1186/1471-2334-13-26.

18.

A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.

19.

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D.

Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. Epub 2012 Aug 8.

20.

Establishment of a new human pneumococcal standard reference serum, 007sp.

Goldblatt D, Plikaytis BD, Akkoyunlu M, Antonello J, Ashton L, Blake M, Burton R, Care R, Durant N, Feavers I, Fernsten P, Fievet F, Giardina P, Jansen K, Katz L, Kierstead L, Lee L, Lin J, Maisonneuve J, Nahm MH, Raab J, Romero-Steiner S, Rose C, Schmidt D, Stapleton J, Carlone GM.

Clin Vaccine Immunol. 2011 Oct;18(10):1728-36. doi: 10.1128/CVI.05252-11. Epub 2011 Aug 18.

21.

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G, Tapia M, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Adegbola RA, Diop D, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, LaForce FM, Preziosi MP.

N Engl J Med. 2011 Jun 16;364(24):2293-304. doi: 10.1056/NEJMoa1003812.

22.

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.

Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, Nahm MH, Ashton L, Haston M, Ekström N, Haikala R, Käyhty H, Henckaerts I, Durant N, Poolman JT, Fernsten P, Yu X, Hu BT, Jansen KU, Blake M, Simonetti ER, Hermans PW, Plikaytis BD.

Clin Vaccine Immunol. 2011 Jan;18(1):135-42. doi: 10.1128/CVI.00370-10. Epub 2010 Nov 17.

23.

Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults.

Burton DC, Flannery B, Bennett NM, Farley MM, Gershman K, Harrison LH, Lynfield R, Petit S, Reingold AL, Schaffner W, Thomas A, Plikaytis BD, Rose CE Jr, Whitney CG, Schuchat A; Active Bacterial Core Surveillance/Emerging Infections Program Network.

Am J Public Health. 2010 Oct;100(10):1904-11. doi: 10.2105/AJPH.2009.181313. Epub 2010 Aug 19.

24.

Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.

Boyer AE, Quinn CP, Hoffmaster AR, Kozel TR, Saile E, Marston CK, Percival A, Plikaytis BD, Woolfitt AR, Gallegos M, Sabourin P, McWilliams LG, Pirkle JL, Barr JR.

Infect Immun. 2009 Aug;77(8):3432-41. doi: 10.1128/IAI.00346-09. Epub 2009 Jun 8.

25.

Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.

Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R.

Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.

26.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
27.

On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data.

Rose CE, Martin SW, Wannemuehler KA, Plikaytis BD.

J Biopharm Stat. 2006;16(4):463-81.

PMID:
16892908
28.

Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.

Park BJ, Arthington-Skaggs BA, Hajjeh RA, Iqbal N, Ciblak MA, Lee-Yang W, Hairston MD, Phelan M, Plikaytis BD, Sofair AN, Harrison LH, Fridkin SK, Warnock DW.

Antimicrob Agents Chemother. 2006 Apr;50(4):1287-92.

29.

Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.

Raghunathan PL, Jones JD, Tiendrebéogo SR, Sanou I, Sangaré L, Kouanda S, Dabal M, Lingani C, Elie CM, Johnson S, Ari M, Martinez J, Chatt J, Sidibe K, Schmink S, Mayer LW, Kondé MK, Djingarey MH, Popovic T, Plikaytis BD, Carlone GM, Rosenstein N, Soriano-Gabarró M.

J Infect Dis. 2006 Mar 1;193(5):607-16. Epub 2006 Jan 30.

PMID:
16453255
30.

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.

Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):540-7. Erratum in: Infect Control Hosp Epidemiol. 2005 Aug;26(8):675.

PMID:
16018429
31.
32.
33.

SARS surveillance during emergency public health response, United States, March-July 2003.

Schrag SJ, Brooks JT, Van Beneden C, Parashar UD, Griffin PM, Anderson LJ, Bellini WJ, Benson RF, Erdman DD, Klimov A, Ksiazek TG, Peret TC, Talkington DF, Thacker WL, Tondella ML, Sampson JS, Hightower AW, Nordenberg DF, Plikaytis BD, Khan AS, Rosenstein NE, Treadwell TA, Whitney CG, Fiore AE, Durant TM, Perz JF, Wasley A, Feikin D, Herndon JL, Bower WA, Klibourn BW, Levy DA, Coronado VG, Buffington J, Dykewicz CA, Khabbaz RF, Chamberland ME.

Emerg Infect Dis. 2004 Feb;10(2):185-94.

34.

Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.

Romero-Steiner S, Frasch C, Concepcion N, Goldblatt D, Käyhty H, Väkeväinen M, Laferriere C, Wauters D, Nahm MH, Schinsky MF, Plikaytis BD, Carlone GM.

Clin Diagn Lab Immunol. 2003 Nov;10(6):1019-24.

35.

Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.

Fry AM, Facklam RR, Whitney CG, Plikaytis BD, Schuchat A.

J Infect Dis. 2003 Sep 1;188(5):643-52. Epub 2003 Aug 18.

PMID:
12934179
36.

Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis.

Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, Plikaytis BD, Perkins BA, Phelan M, Levett PN, Weyant RS.

J Clin Microbiol. 2003 Feb;41(2):803-9.

37.

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH Jr, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.

Emerg Infect Dis. 2002 Oct;8(10):1103-10.

38.

Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.

Leake JA, Kone ML, Yada AA, Barry LF, Traore G, Ware A, Coulibaly T, Berthe A, Mambu Ma Disu H, Rosenstein NE, Plikaytis BD, Esteves K, Kawamata J, Wenger JD, Heymann DL, Perkins BA.

Bull World Health Organ. 2002;80(5):342-9.

39.

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW.

Clin Infect Dis. 2001 Sep 1;33(5):641-7. Epub 2001 Jul 30. Review.

PMID:
11486286
40.

Risk factors associated with leptospirosis in northeastern Thailand, 1998.

Tangkanakul W, Tharmaphornpil P, Plikaytis BD, Bragg S, Poonsuksombat D, Choomkasien P, Kingnate D, Ashford DA.

Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):204-8.

PMID:
11388516
41.

Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996.

Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D, Vugia D, Reingold A, Talbot R, Plikaytis BD, Perkins BA, Hajjeh RA.

Clin Infect Dis. 2001 Mar 1;32(5):708-15. Epub 2001 Feb 28.

PMID:
11229838
42.

Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.

Sacchi CT, Whitney AM, Popovic T, Beall DS, Reeves MW, Plikaytis BD, Rosenstein NE, Perkins BA, Tondella ML, Mayer LW.

J Infect Dis. 2000 Oct;182(4):1169-76. Epub 2000 Sep 8.

PMID:
10979914
43.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Plikaytis BD, Goldblatt D, Frasch CE, Blondeau C, Bybel MJ, Giebink GS, Jonsdottir I, Käyhty H, Konradsen HB, Madore DV, Nahm MH, Schulman CA, Holder PF, Lezhava T, Elie CM, Carlone GM.

J Clin Microbiol. 2000 Jun;38(6):2043-50.

44.

Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention.

Woods CW, McRill C, Plikaytis BD, Rosenstein NE, Mosley D, Boyd D, England B, Perkins BA, Ampel NM, Hajjeh RA.

J Infect Dis. 2000 Apr;181(4):1428-34. Epub 2000 Apr 7.

PMID:
10753734
45.

Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997.

Leake JA, Mosley DG, England B, Graham JV, Plikaytis BD, Ampel NM, Perkins BA, Hajjeh RA.

J Infect Dis. 2000 Apr;181(4):1435-40. Epub 2000 Apr 7.

PMID:
10753733
46.

Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.

Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plikaytis BD, Carlone GM.

Clin Infect Dis. 1999 Aug;29(2):281-8.

PMID:
10476727
47.
48.

Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger.

Campagne G, Garba A, Schuchat A, Boulanger D, Plikaytis BD, Ousseini M, Chippaux JP.

Am J Trop Med Hyg. 1998 Nov;59(5):837-42.

PMID:
9840608
49.

A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses.

Granoff DM, Maslanka SE, Carlone GM, Plikaytis BD, Santos GF, Mokatrin A, Raff HV.

Clin Diagn Lab Immunol. 1998 Jul;5(4):479-85.

50.

Comparison of a pneumococcal common protein (PsaA) antibody ELISA and a PsaA immune complex ELISA for detection of pneumococcal serum antibody.

Tharpe JA, Russell H, Leinonen M, Plikaytis BD, Breiman RF, Carlone GM, Ades EW, Sampson JS.

Pathobiology. 1998;66(2):77-83.

PMID:
9645631

Supplemental Content

Loading ...
Support Center